ADC Therapeutics Raises $86.6 Million in Financing, Amends Loan and Royalty Deals
ADC Therapeutics announced a $86.6 million private placement of common shares and pre-funded warrants, alongside amendments to its Blue Owl loan and HCR royalty agreements. The loan amendment follows a $70 million prepayment.
6 million private placement and amendments to its debt and royalty agreements. The company will issue common shares and pre-funded warrants and has signed a loan amendment with Blue Owl that, after a $70 million prepayment, l…